Zou JJ - Search Results

1

Real polymer-free sirolimus- and probucol-eluting versus biodegradable polymer sirolimus-eluting stents for obstructive coronary artery disease: DKPLUS-Wave 1, a multicenter, randomized, prospective trial.

Chen SL, Ye F, Zhang JJ, Zou JJ, Qian XS, Li F, Yang S, Ge Z, Shan SJ, Li XB, Xu T, Kan J, Lin L, Han YL. Chen SL, et al. Among authors: zou jj. Cardiovasc Ther. 2013 Aug;31(4):193-200. doi: 10.1111/j.1755-5922.2012.00319.x. Cardiovasc Ther. 2013. PMID: 22954234 Free article. Clinical Trial.

2

Individual variability in the disposition of and response to clopidogrel: pharmacogenomics and beyond.

Xie HG, Zou JJ, Hu ZY, Zhang JJ, Ye F, Chen SL. Xie HG, et al. Among authors: zou jj. Pharmacol Ther. 2011 Mar;129(3):267-89. doi: 10.1016/j.pharmthera.2010.10.001. Epub 2010 Oct 19. Pharmacol Ther. 2011. PMID: 20965214 Review.

3

Influence of CYP2C19 loss-of-function variants on the antiplatelet effects and cardiovascular events in clopidogrel-treated Chinese patients undergoing percutaneous coronary intervention.

Zou JJ, Xie HG, Chen SL, Tan J, Lin L, Zhao YY, Xu HM, Lin S, Zhang J, Wang GJ. Zou JJ, et al. Eur J Clin Pharmacol. 2013 Apr;69(4):771-7. doi: 10.1007/s00228-012-1392-5. Epub 2012 Sep 22. Eur J Clin Pharmacol. 2013. PMID: 23001453 Clinical Trial.

4

Pharmacokinetics of clopidogrel in healthy Chinese volunteers.

Zou JJ, Ding L, Tan J, Fan HW, Wang GJ, Chen SL. Zou JJ, et al. Pharmazie. 2012 Sep;67(9):792-4. Pharmazie. 2012. PMID: 23016453

5

Efffect of the ABCC3 -211C/T polymorphism on clopidogrel responsiveness in patients with percutaneous coronary intervention.

Zou JJ, Fan HW, Chen SL, Tan J, He BS, Xie HG. Zou JJ, et al. Clin Exp Pharmacol Physiol. 2013 Aug;40(8):504-9. doi: 10.1111/1440-1681.12118. Clin Exp Pharmacol Physiol. 2013. PMID: 23692149

6

Increased risk for developing major adverse cardiovascular events in stented Chinese patients treated with dual antiplatelet therapy after concomitant use of the proton pump inhibitor.

Zou JJ, Chen SL, Tan J, Lin L, Zhao YY, Xu HM, Lin S, Zhang J, Fan HW, Xie HG. Zou JJ, et al. PLoS One. 2014 Jan 8;9(1):e84985. doi: 10.1371/journal.pone.0084985. eCollection 2014. PLoS One. 2014. PMID: 24416326 Free PMC article.

7

CES1A -816C as a genetic marker to predict greater platelet clopidogrel response in patients with percutaneous coronary intervention.

Zou JJ, Chen SL, Fan HW, Tan J, He BS, Xie HG. Zou JJ, et al. J Cardiovasc Pharmacol. 2014 Feb;63(2):178-83. doi: 10.1097/FJC.0000000000000037. J Cardiovasc Pharmacol. 2014. PMID: 24508947

8

Association of the use of amlodipine with clopidogrel response in Chinese patients undergoing percutaneous coronary intervention.

Liu XQ, Lin S, Qiu LL, Lin L, Zhao YY, Xu HM, Zhang J, Zou JJ. Liu XQ, et al. Among authors: zou jj. Pharmazie. 2014 Nov;69(11):814-7. Pharmazie. 2014. PMID: 25985576

9

Using machine learning to predict stroke-associated pneumonia in Chinese acute ischaemic stroke patients.

Li X, Wu M, Sun C, Zhao Z, Wang F, Zheng X, Ge W, Zhou J, Zou J. Li X, et al. Eur J Neurol. 2020 Aug;27(8):1656-1663. doi: 10.1111/ene.14295. Epub 2020 May 31. Eur J Neurol. 2020. PMID: 32374076

10

Pharmacokinetic and bioequivalence comparison of a single 100-mg dose of cefteram pivoxil powder suspension and tablet formulations: a randomized-sequence, open-label, two-period crossover study in healthy Chinese adult male volunteers.

Zou J, Di B, Wu CY, Hu Q, Li JH, Zhu Y, Fan H, Xiao D, Wang GJ. Zou J, et al. Clin Ther. 2008 Apr;30(4):654-60. doi: 10.1016/j.clinthera.2008.04.003. Clin Ther. 2008. PMID: 18498914 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

296 results

Search Page

Filters